| [1] Hilderbrand R L. The Role of Phosphonates in Living Systems[M]. CRC Press,Boca Raton,1983.[2] Bellucci C,Gualtieri F,Scapecchi S,et al. Negative Inotropic and Calcium-antagonist Activity of Alkil and Arylalkyl Phosphonates[J]. II Farmaco,1989,44:1167-1191.[3] Kafarski P,Lejczak B. Biological Activity of Aminophosphonic Acids[J]. Phosphorus Sulfur Silicon Relat Elem,1991,63:193-215.[4] Savignac P,Iorga B. Morden Phosphonate Chemistry[M]. CRC Press,Boca Raton,2003.[5] Hayashi T,Senda T,Takaya Y,et al. Rhodium-Catalyzed Asymmetric 1,4-Addition to 1-Alkenylphosphonates[J]. J Am Chem Soc,1999,121:11591-11592.[6] Duan Z C,Hu X P,Wang D Y,et al. Cu-Catalyzed Asymmetric Conjugate Reduction of β-Substituted α,β-Unsaturated Phosphonates:an Efficient Synthesis of Optically Active β-Stereogenic Alkylphosphonates[J]. Tetrahedron Lett,2009,50:6720-6722. [7] de Vries J G. The Handbook of Homogeneous Hydrogenation[M]. Wiley-VCH:Weinheim,Germany,2007:1-3.[8] Duan Z C,Hu X P,Wang D Y,et al. Enantioselective Synthesis of Optically Active Alkanephosphonates via Rhodium-Catalyzed Asymmetric Hydrogenation of beta-Substituted alpha,beta-Unsaturated Phosphonates with Ferrocene-based Monophosphoramidite Ligands[J]. Adv Synth Catal,2008,350:1979-1983.[9] Duan Z C,Hu X P,Zhang C,et al. Highly Enantioselective Rh-Catalyzed Hydrogenation of β,γ-Unsaturated Phosphonates with Chiral Ferrocene-Based Monophosphoramidite Ligands[J]. J Org Chem,2009,74:9191-9194.[10] Luo L B,Wang D Y,Zhou X M,et al. Asymmetric Synthesis of 2-Alkyl-3-Phosphonopropanoic Acid Derivatives via Rh-Catalyzed Asymmetric Hydrogenation[J]. Tetrahedron:Asymm,2011,22:2117-2123.[11] Duan Z C,Wang L Z,Song X J,et al. Enantioselective Synthesis of Optically Active Alkylphosphonates via Rh-Catalyzed Asymmetric Hydrogenation of β-Substituted α,β-Unsaturated Phosphonates[J]. Tetrahedron:Asymm,2012,23:508-514. |
